PUT - SPRINTER OPEN END - AMGEN | Market Closed - Deutsche Boerse AG 01:44:10 2024-06-03 pm EDT | ||
| 7.34 EUR | -2.52% |
|
| Current month | -2.52% | ||
| 1 month | +6.07% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-03 | 7.34 | -2.52% |
| 24-05-31 | 7.53 | -2.21% |
| 24-05-30 | 7.7 | -6.89% |
| 24-05-29 | 8.27 | +3.37% |
| 24-05-28 | 8 | +12.20% |
Delayed Quote Deutsche Boerse AG
Last update June 03, 2024 at 01:44 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM9RJ2 |
| ISIN | DE000VM9RJ23 |
| Date issued | 2024-02-05 |
| Strike | 385.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.28 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.77 € |
|---|---|
| Lowest since issue | 5.76 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
307.4
USD
Average target price
316.3
USD
Spread / Average Target
+2.88%
- Stock Market
- Certificates
- Certificat
